246 related articles for article (PubMed ID: 14594996)
1. Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome.
Keller RK; Arnold TP; Fliesler SJ
J Lipid Res; 2004 Feb; 45(2):347-55. PubMed ID: 14594996
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol deficit but not accumulation of aberrant sterols is the major cause of the teratogenic activity in the Smith-Lemli-Opitz syndrome animal model.
Gaoua W; Wolf C; Chevy F; Ilien F; Roux C
J Lipid Res; 2000 Apr; 41(4):637-46. PubMed ID: 10744785
[TBL] [Abstract][Full Text] [Related]
3. Abnormal cholesterol biosynthesis as in Smith-Lemli-Opitz syndrome disrupts normal skeletal development in the rat.
Kolf-Clauw M; Chevy F; Ponsart C
J Lab Clin Med; 1998 Mar; 131(3):222-7. PubMed ID: 9523845
[TBL] [Abstract][Full Text] [Related]
4. Hepatic isoprenoid metabolism in a rat model of Smith-Lemli-Opitz Syndrome.
Keller RK; Mitchell DA; Goulah CC; Fliesler SJ
Lipids; 2013 Mar; 48(3):219-29. PubMed ID: 23361583
[TBL] [Abstract][Full Text] [Related]
5. Compromised phagosome maturation underlies RPE pathology in cell culture and whole animal models of Smith-Lemli-Opitz Syndrome.
Ramachandra Rao S; Pfeffer BA; Más Gómez N; Skelton LA; Keiko U; Sparrow JR; Rowsam AM; Mitchell CH; Fliesler SJ
Autophagy; 2018; 14(10):1796-1817. PubMed ID: 29979914
[TBL] [Abstract][Full Text] [Related]
6. Oxysterols and Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome: Implications for an Improved Therapeutic Intervention.
Fliesler SJ; Xu L
Molecules; 2018 Oct; 23(10):. PubMed ID: 30360379
[TBL] [Abstract][Full Text] [Related]
7. An efficient synthesis of 4α- and 4β-hydroxy- 7-dehydrocholesterol, biomarkers for patients with and animal models of the Smith-Lemli-Opitz syndrome.
Kawamoto H; Ohmori Y; Maekawa M; Shimada M; Mano N; Iida T
Chem Phys Lipids; 2013; 175-176():73-8. PubMed ID: 23920082
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 7-dehydrocholesterol reductase by the teratogen AY9944: a rat model for Smith-Lemli-Opitz syndrome.
Kolf-Clauw M; Chevy F; Wolf C; Siliart B; Citadelle D; Roux C
Teratology; 1996 Sep; 54(3):115-25. PubMed ID: 8987154
[TBL] [Abstract][Full Text] [Related]
9. Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features.
Fliesler SJ; Peachey NS; Richards MJ; Nagel BA; Vaughan DK
Arch Ophthalmol; 2004 Aug; 122(8):1190-200. PubMed ID: 15302661
[TBL] [Abstract][Full Text] [Related]
10. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
Xu L; Sheflin LG; Porter NA; Fliesler SJ
Biochim Biophys Acta; 2012 Jun; 1821(6):877-83. PubMed ID: 22425966
[TBL] [Abstract][Full Text] [Related]
11. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.
Xu L; Liu W; Sheflin LG; Fliesler SJ; Porter NA
J Lipid Res; 2011 Oct; 52(10):1810-20. PubMed ID: 21817059
[TBL] [Abstract][Full Text] [Related]
12. Precholesterol sterols accumulate in lipid rafts of patients with Smith-Lemli-Opitz syndrome and X-linked dominant chondrodysplasia punctata.
Rakheja D; Boriack RL
Pediatr Dev Pathol; 2008; 11(2):128-32. PubMed ID: 17378665
[TBL] [Abstract][Full Text] [Related]
13. Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7alpha-hydroxylase and 27-hydroxylase activities in rat liver.
Honda A; Salen G; Shefer S; Batta AK; Honda M; Xu G; Tint GS; Matsuzaki Y; Shoda J; Tanaka N
J Lipid Res; 1999 Aug; 40(8):1520-8. PubMed ID: 10428990
[TBL] [Abstract][Full Text] [Related]
14. Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.
Vaughan DK; Peachey NS; Richards MJ; Buchan B; Fliesler SJ
Exp Eye Res; 2006 Mar; 82(3):496-504. PubMed ID: 16360150
[TBL] [Abstract][Full Text] [Related]
15. 7DHC-induced changes of Kv1.3 operation contributes to modified T cell function in Smith-Lemli-Opitz syndrome.
Balajthy A; Somodi S; Pethő Z; Péter M; Varga Z; Szabó GP; Paragh G; Vígh L; Panyi G; Hajdu P
Pflugers Arch; 2016 Aug; 468(8):1403-18. PubMed ID: 27315086
[TBL] [Abstract][Full Text] [Related]
16. Marked alteration of sterol metabolism and composition without compromising retinal development or function.
Fliesler SJ; Richards MJ; Miller C; Peachey NS
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1792-801. PubMed ID: 10393050
[TBL] [Abstract][Full Text] [Related]
17. Signaling by the human serotonin(1A) receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome.
Paila YD; Murty MR; Vairamani M; Chattopadhyay A
Biochim Biophys Acta; 2008 Jun; 1778(6):1508-16. PubMed ID: 18381059
[TBL] [Abstract][Full Text] [Related]
18. Variant RSH/Smith-Lemli-Opitz syndrome with atypical sterol metabolism.
Anderson AJ; Stephan MJ; Walker WO; Kelley RI
Am J Med Genet; 1998 Aug; 78(5):413-8. PubMed ID: 9714006
[TBL] [Abstract][Full Text] [Related]
19. Role of cholesterol in embryonic development.
Roux C; Wolf C; Mulliez N; Gaoua W; Cormier V; Chevy F; Citadelle D
Am J Clin Nutr; 2000 May; 71(5 Suppl):1270S-9S. PubMed ID: 10799401
[TBL] [Abstract][Full Text] [Related]
20. Lipidomic analysis of the retina in a rat model of Smith-Lemli-Opitz syndrome: alterations in docosahexaenoic acid content of phospholipid molecular species.
Ford DA; Monda JK; Brush RS; Anderson RE; Richards MJ; Fliesler SJ
J Neurochem; 2008 May; 105(3):1032-47. PubMed ID: 18182048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
